About Contact Us Careers

HIV Drugs Market Trends

Request Free Sample Copy

Report ID: 162
Published Date: Sep 05, 2024
Report Format: PDF, PPT

Buy Now

HIV Drugs Market Trends

Growth Drivers

Surging Cases of Cancer Worldwide
Rising Initiatives by the Governments

Challenges

Lack of Awareness Regarding the Treatment

HIV Drugs Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	6.1%
Base Year Market Size (2023)	USD 34.61 billion
Forecast Year Market Size (2036)	USD 74.73 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

HIV Drugs Market Size | Growth Forecast Report 2036

Author Credits: Radhika Pawar

Report ID: 162
Published Date: Sep 05, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of HIV drugs is evaluated at USD 36.3 billion.

HIV Drugs Market size was valued at USD 34.61 billion in 2023 and is set to cross USD 74.73 billion by 2036, registering more than 6.1% CAGR during the forecast period i.e., between 2024-2036. The surging AIDS cases worldwide will impel the market growth.

North America is likely to dominate majority revenue share by 2036, on the back of presence of an ultra-modern healthcare system.

The major players in the market are F. Hoffmann-La Roche Ltd, Cipla Inc., Teva Pharmaceuticals Industries Ltd. and Janssen Global Services, LLC.

Inquiry Before Buying Request Free Sample